EVIO (EVIO) EV-to-EBIT: -0.00 (As of Jul. 16, 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

What is EVIO EV-to-EBIT?

EVIO EVIO -98.00% EV-to-EBIT is -0.00 as of Jul. 16, 2026.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, EVIO's Enterprise Value is $0.02 Mil. EVIO's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was $-5.46 Mil. Therefore, EVIO's EV-to-EBIT for today is -0.00.

The historical rank and industry rank for EVIO's EV-to-EBIT or its related term are showing as below:

EVIO's EV-to-EBIT is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 15.86
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. EVIO's Enterprise Value for the quarter that ended in Jun. 2020 was $14.97 Mil. EVIO's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 was $-5.46 Mil. EVIO's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2020 was -36.47%.

EVIO (OTCPK:EVIO) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

EVIO's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2020 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2020 )	=	EBIT	/	Enterprise Value (Q: Jun. 2020 )
	=	-5.461	/	14.97383385
	=	-36.47 %

EVIO's Enterprise Value for the quarter that ended in Jun. 2020 was $14.97 Mil.
EVIO's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.46 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EVIO EV-to-EBIT Related Terms

EVIO EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for EVIO's EV-to-EBIT can be seen below:

EVIO EV-to-EBIT Chart

EVIO Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

EV-to-EBIT

-4.44

-7.39

-6.49

-3.63

-3.25

EVIO Quarterly Data
	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20
EV-to-EBIT	Get a 7-Day Free Trial															-3.27	-3.25	-2.22	-2.21	-2.74

EVIO vs VCBD, ACCA, LITH: EV-to-EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, EVIO's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

EVIO EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EVIO's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where EVIO's EV-to-EBIT falls into.

Save Embed

EVIO EV-to-EBIT Calculation

EVIO's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	0.021	/	-5.461
	=	-0.00

EVIO's current Enterprise Value is $0.02 Mil.
EVIO's EBIT for the trailing twelve months (TTM) ended in Jun. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.46 Mil.

Frequently Asked Questions Learn more about EV-to-EBIT →

What does a EV-to-EBIT of -0.00 mean?

EVIO (EVIO) has a EV-to-EBIT of -0.00 as of Jul. 16, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on EVIO and its competitors.

Is EVIO's EV-to-EBIT too high?

EVIO's current EV-to-EBIT is -0.00.

How does EVIO's EV-to-EBIT compare to VCBD and ACCA?

EVIO's EV-to-EBIT of -0.00 can be compared against companies in the Drug Manufacturers industry. The industry median EV-to-EBIT is 15.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EV-to-EBIT for a Drug Manufacturers company?

The median EV-to-EBIT among Drug Manufacturers companies is 15.86, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EV-to-EBIT mean?

A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on EVIO and its competitors. For the Drug Manufacturers industry, the median EV-to-EBIT is 15.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EVIO's current EV-to-EBIT is -0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is EVIO stock overvalued right now?

EVIO (EVIO) has a current EV-to-EBIT of -0.00. The current EV-to-EBIT is -0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EV-to-EBIT calculated?

EV-to-EBIT is calculated from a company's financial statements. For EVIO (EVIO), the current EV-to-EBIT is -0.00 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EVIO Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies VCBD ACCA LITH KOAN BSPK PCYN MCOA CNABQ ETST THCT ZTS TSE:4502 XTER:MRK HKSE:03692 TSE:4523 SZSE:000661 TSE:4507 SZSE:000538 NSE:SUNPHARMA SZSE:300601

Address 2654 W. Horizon Ridge Drive Parkway, Suite B5-208, Henderson, NV, USA, 89052

Website http://www.evioinc.com

EVIO Inc is a Colorado corporation and a diversified holding company. Its subsidiaries provide analytical testing and advisory services to the emerging legalized cannabis industry. The Company performs analytical testing for cannabis and cannabis-derived products, including hemp and CBD products. Its current operations also include pharmaceutical, environmental, stability, and analytical testing, as well as residential and commercial construction and investments, with operations in the United States and Canada.